Literature DB >> 33015812

Protective efficacy of probiotics on the treatment of acute rotavirus diarrhea in children: an updated meta-analysis.

J-B Di1, Z-T Gai.   

Abstract

OBJECTIVE: This meta-analysis aims to uncover the therapeutic efficacy of probiotics on acute rotavirus diarrhea (RVD) in children.
MATERIALS AND METHODS: Randomized controlled studies reporting therapeutic efficacy of probiotics on acute RVD in children published before 1st June 2019 were searched in PubMed, EMBASE, and Cochrane. The citations in all searched literature were manually examined. Data were extracted from eligible literature for calculating STD Mean Difference (SMD) and its corresponding 95% confidence interval (CI). Subsequently, the association between therapeutic efficacy of probiotics and acute RVD in children was evaluated. Moreover, data were weighted by an inverse variance and analyzed by a fixed or random effect model. Heterogeneity test was applied in the enrolled literature. Sensitivity and publication bias was examined. STATA 12.0 was used for meta-analysis.
RESULTS: A total of 19 independent Randomized Controlled Trials (RCTs) involving 1,624 children with acute RVD were enrolled in this study. Three pieces of literature were excluded through sensitivity and publication bias analyses. Data extracted from eligible literature indicated that probiotics could markedly reduce the occurrence of acute RVD in children (SMD=-0.49, 95% CI=-0.74-0.25). Subgroup analysis conducted based on ethnicity uncovered a poor therapeutic efficacy of probiotics on reducing the occurrence of acute RVD in Asian children (SMD=-0.45, 95% CI=-0.94-0.04), which was markedly significant in Caucasian children (SMD=-0.54, 95% CI=-0.78--0.30). In addition, the subgroup analysis based on the probiotic subtypes found a pronounced efficacy of both Lactobacillus acidophilus (SMD=-0.67, 95% CI=-0.92-0.42) and non-Lactobacillus acidophilus probiotic (SMD=-0.45, 95% CI=-0.77-0.14) on the occurrence of acute RVD in children.
CONCLUSIONS: Probiotics could reduce the occurrence of acute RVD in children, especially in Caucasian population. Our findings still needed to be further validated in a multi-center institution with larger sample size and more qualified data.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33015812     DOI: 10.26355/eurrev_202009_23057

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Efficacy of probiotics in the treatment of acute diarrhea in children: a systematic review and meta-analysis of clinical trials.

Authors:  Rao Huang; Hong-Yi Xing; Hong-Juan Liu; Ze-Fu Chen; Bi-Bo Tang
Journal:  Transl Pediatr       Date:  2021-12

2.  Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial.

Authors:  Vladimir Ivashkin; Victor Fomin; Sergey Moiseev; Michail Brovko; Roman Maslennikov; Anatoly Ulyanin; Victoria Sholomova; Maria Vasilyeva; Elizaveta Trush; Oleg Shifrin; Elena Poluektova
Journal:  Probiotics Antimicrob Proteins       Date:  2021-10-13       Impact factor: 5.265

Review 3.  Best Practices for Probiotic Research in Athletic and Physically Active Populations: Guidance for Future Randomized Controlled Trials.

Authors:  Alex E Mohr; Jamie Pugh; Orla O'Sullivan; Katherine Black; Jeremy R Townsend; David B Pyne; Floris C Wardenaar; Nicholas P West; Corrie M Whisner; Lynne V McFarland
Journal:  Front Nutr       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.